What is the pathophysiology of gastroparesis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathophysiology of Gastroparesis

Gastroparesis is characterized by delayed gastric emptying in the absence of mechanical obstruction, resulting from a complex interplay of neuromuscular dysfunction affecting gastric motility, accommodation, and sensory function. 1

Core Pathophysiological Mechanisms

Gastric Motor Dysfunction

  • Antral hypomotility: Reduced contractility of the gastric antrum impairs the grinding and propulsion of food particles 1
  • Pyloric dysfunction: Pylorospasm characterized by prolonged intermittent contractions and increased baseline tone impedes gastric emptying 1
  • Antroduodenal and pyloric dyscoordination: Disrupted coordination between antral contractions and pyloric relaxation prevents proper food passage 1

Impaired Gastric Accommodation

  • Reduced ability of the proximal stomach (fundus) to relax and accommodate food
  • Associated with early satiety, postprandial fullness, and weight loss 1
  • Contributes to symptoms independently of delayed emptying 1

Altered Visceral Sensitivity

  • Visceral hypersensitivity: Increased perception of gastric stimuli, including distension and chemical stimuli 1
  • Mechanical sensitivity to balloon distension is increased following meals and associates with postprandial pain 1
  • Chemical sensitivity to acid infusion worsens symptoms, particularly nausea 1

Neural Dysfunction

  • Vagal nerve injury: Disruption of vagal afferent and efferent pathways 1
  • Enteric nervous system damage: Loss of interstitial cells of Cajal (ICC), which are pacemaker cells that regulate gastric motility 1
  • Autonomic neuropathy: Particularly relevant in diabetic gastroparesis 1

Etiology-Specific Pathophysiology

Diabetic Gastroparesis

  • Accounts for approximately 25% of gastroparesis cases 1
  • Diabetic neuropathy linked to antral hypomotility and pylorospasm 1
  • Hyperglycemia directly impairs gastric motility and increases perception of gastrointestinal sensations 1
  • Loss of ICC and CD206+ macrophages in the gastric wall 1

Post-Surgical Gastroparesis

  • Typically due to partial or complete vagotomy (intended or unintended) 1
  • Common after procedures like esophagectomy, gastrectomy, and fundoplication 1

Idiopathic Gastroparesis

  • Most common form, often following viral infections 1
  • May involve immune-mediated damage to the enteric nervous system 1

Pathophysiological Impact on Symptoms

  • Nausea and vomiting: Related to gastric dysrhythmias, antral hypomotility, and increased visceral sensitivity 1
  • Early satiety and postprandial fullness: Associated with impaired gastric accommodation and delayed emptying 1
  • Abdominal pain: Linked to visceral hypersensitivity and altered central processing of sensory signals 1
  • Bloating: Result of impaired gastric emptying and intestinal dysmotility 1

Metabolic and Nutritional Consequences

  • Disrupted coordination between nutrient delivery and insulin action in diabetic patients 1
  • "Gastric hypoglycemia" in insulin-treated patients due to mismatched insulin action and delayed nutrient absorption 1
  • Malnutrition and weight loss due to reduced oral intake and malabsorption 1

Emerging Concepts

  • Gastroparesis and functional dyspepsia may represent a spectrum of the same pathophysiological disorder rather than distinct entities 1
  • Altered intestinal permeability and changes in the gastric and small bowel microbiome may contribute to symptom generation 1
  • Central nervous system processing abnormalities affect symptom perception and intensity 1

Understanding these complex and often overlapping pathophysiological mechanisms is essential for developing targeted therapeutic approaches for patients with gastroparesis.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.